Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine

Hepatology

Volumn 26, Issue 2, 1997, Pages 288-294

  Enjoji, Munechika ^a,c   Nakashima, Manabu ^b   Honda, Masanao ^a   Sakai, Hironori ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; AZACITIDINE; INTEGRIN; THROMBOPOIETIN;

ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL TRANSFORMATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SARCOMA CELL; XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL DIFFERENTIATION; CHOLANGIOCARCINOMA; HUMANS; LIVER; MICE; NEOPLASM TRANSPLANTATION; PHENOTYPE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 0030852746     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260206     Document Type: Article

References (15)

1. Nakajima T, Tajima Y, Sugano I, Nagao K, Kondo Y, Wada K. Intrahepatic cholangiocarcinoma with sarcomatous change. Cancer 1993;72:1872-1877.
2. Haratake J, Horie A. An immunohistochemical study of sarcomatoid liver carcinomas. Cancer 1991;68:93-97.
3. Haratake J, Yamada H, Horie A, Inokuma T. Giant cell tumor-like cholangiocarcinoma associated with systemic cholelithiasis. Cancer 1992;69:2444-2448.
4. Sell S. Is there a liver stem cell? Cancer Res 1990;50:3811-3815.
5. Sigal SH, Brill S, Fiorino AS, Reid LM. The liver as a stem cell and lineage system. Am J Physiol 1992;263:G139-G148.
6. Sell S, Dunaford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989;134:1347-1363.
7. Hixson DC, Paris RA, Thompson ML. An antigenic portrait of the liver during carcinogenesis. Pathobiology 1990;58:65-77.
8. Shiojiri N, Lemire JM, Fausto N. Cell lineages and oval cell progenitors in rat liver development. Cancer Res 1991;51:2611-2620.
9. Sell S, Salman J. Light- and electron-microscopic autoradiographic analysis of proliferating cells during the early stages of chemical hepatocarcinogenesis in the rat induced by feeding N-2-fluorenylacetamide in a choline-deficient diet. Am J Pathol 1984;114:287-300.
10. Factor VM, Radaeva SA, Thorgeirsson SS. Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol 1994;145:409-422.
11. Faris RA, Monfils BA, Dunsford HA, Hixson DC. Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte" model system. Cancer Res 1991;51:1308-1317.
12. Dabeva MD, Shafritz DA. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration. Am J Pathol 1993;143:1606-1620.
13. Germain L, Noel M, Gourdeau H, Marceau N. Promotion of growth and differentiation of rat ductular oval cells in primary culture. Cancer Res 1988;48:368-378.
14. Lenzi R, Liu MH, Tarsetti F, Slott PA, Alpini G, Zhai W, Paronetto F, et al. Histogenesis of bile duct-like cells proliferating during ethionine hepatocarcinogenesis. Lab Invest 1992;66:390-402.
15. Sarraf C, Lalani E, Golding M, Anikumar TV, Poulsom R, Alison M. Cell behavior in the acetylaminofluorene-treated regenerating rat liver. Am J Pathol 1994;145:1114-1126.